Global Prenatal And Newborn Genetic Testing Market Forecast 2029: Size, Share, and Competitive Landscape

Global Prenatal And Newborn Genetic Testing Market

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Prenatal And Newborn Genetic Testing Market In The Coming Years?

The market size for prenatal and newborn genetic testing has seen a swift surge in recent years. Predictions suggest an increase from $6.68 billion in 2024 to an impressive $7.6 billion in 2025, showing a compound annual growth rate (CAGR) of 13.7%. The phenomenal growth recorded in the past can be linked to advancements in non-invasive prenatal tests, a rise in maternal age, backing from government and healthcare policies, and a rising patient demand for early detection.

A significant expansion is predicted in the prenatal and newborn genetic testing market in the upcoming years. The growth is anticipated to hit $12.07 billion by 2029, with a compound annual growth rate (CAGR) of 12.3%. Factors such as increased genetic test panels, heightened awareness about maternal health, guidelines for prenatal and newborn screening, a rising focus on rare illnesses, and ethical and regulatory considerations contribute to this expected growth. During this forecast period, trends such as non-invasive prenatal testing (NIPT), whole genome sequencing (WGS), whole exome sequencing, the integration of artificial intelligence (AI), preimplantation genetic testing (PGT) and direct-to-consumer genetic testing, are set to emerge.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Prenatal And Newborn Genetic Testing Market?

The progression of prenatal and newborn genetic testing markets is projected to be fueled by governmental programs and assistance towards prenatal examinations and newborn genetic assessments. Governmental programs typically outline distinct operations, policies, or projects employed by governmental bodies at various levels – local, regional, national – to address specific issues, achieve certain objectives, or enhance the living standards of its populace. These programs meant for prenatal and newborn genetic analysis aids citizens by assisting in the detection of genetic anomalies or disorders in unborn children during gestation or in infants shortly after their birth. For example, the Australian government in June 2022 sanctioned $1.3 million per annum for the newborn testing program in New South Wales (NSW), a state on Australia’s eastern flank. This program provides free tests for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA), which includes newborn genetic evaluation and screening, to every newborn in the state. An estimated 100,000 infants would be beneficiaries of these tests annually, potentially saving up to 13 infants who are suspected to have these genetic diseases. Hence, governmental programs and backing for prenatal examinations and newborn genetic assessments act as catalysts for the growth of the prenatal and newborn genetic testing markets.

Which Sub-Segments Are Driving Growth Within The Prenatal And Newborn Genetic Testing Market?

The prenatal and newborn genetic testingmarket covered in this report is segmented –

1) By Product Type: Consumables; Instruments

2) By Screening: Non-Invasive Prenatal Testing; Chronic Villus Sampling; Amniocentesis; Maternal Serum Screening; Other Screenings

3) By Disease: Down Syndrome; Phenylketonuria; Cystic Fibrosis; Sickle Cell Anemia

4) By End User: Hospital; Maternity And Specialty Clinics; Diagnostic Centers

Subsegments:

1) By Consumables: Reagents And Assays; Sample Collection Kits; Test Kits

2) By Instruments: Polymerase Chain Reaction (PCR) Machines; Sequencers; Microarray Analyzers

What Current And Upcoming Trends Are Shaping The Prenatal And Newborn Genetic Testing Market?

Major firms in the marketplace for prenatal and neonatal genetic tests are focusing their efforts on developing cutting-edge screening examinations, such as noninvasive prenatal exams, which are more affordable and accessible, and promise dependable service for clients. Noninvasive prenatal screenings (NIPS), alternatively known as noninvasive prenatal tests (NIPT), are sophisticated and secure genetic screening procedures employed during gestation to evaluate the potential risk of certain chromosomal disorders in the fetus. For instance, Juno Diagnostics Inc., a medical technology firm based in the US, introduced ‘Juno Hazel’ in November 2022, a noninvasive prenatal screening test capable of identifying chromosomal abnormalities and providing clinical information. The test employs a sample collection kit, eradicates the need for phlebotomy, and escalates accessibility. The firm intends to supply educational materials and tailored genetic counseling support by teaming up with physicians and genetic advisors.

Which Players Are Shaping The Competitive Landscape Of The Prenatal And Newborn Genetic Testing Market?

Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech PLC, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

How Do Regional Dynamics Influence The Prenatal And Newborn Genetic Testing Market Performance?

North America was the largest region in the prenatal and newborn genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13158&type=smp

Browse Through More Reports Similar to the Global Prenatal And Newborn Genetic Testing Market 2025, By The Business Research Company

Endotoxin Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/endotoxin-testing-global-market-report

Heavy Metal Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/heavy-metal-testing-global-market-report

5G Device Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/5g-device-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model